A rare presentation of primary apla and pulmonary thrombolism
DOI:
https://doi.org/10.18203/2349-3933.ijam20230370Keywords:
Pulmonary thromboembolism, Antiphospholipid syndrome, HemoptysisAbstract
Antiphospholipid syndrome (APS) is a state of hypercoagulation, causing thrombus in artery, vein and capillaries, with or without obstetrical events with the presence of autoantibodies, which includes lupus anticoagulant, anticardiolipin antibodies and anti-β2-glycoprotein 1 antibodies. It has variable clinical presentations such as vascular thrombosis and obstetrical complications, pulmonary thromboembolism (PTE), pulmonary hypertension, and acute respiratory distress syndrome. Hereby we presented a case of young male who came to our hospital with hemoptysis and isolated pulmonary embolism, with the background of APS which is rare. Hemoptysis and pulmonary thromboembolism both being fatal emergencies requiring completely different management methods.
References
Schreiber K, Sciascia S, Groot PG, Devreese K, Jacobsen S, Ruiz-Irastorza G, et al. Antiphospholipid syndrome. Nat Rev Dis Primers. 2018;4:17103.
Maioli G, Calabrese G, Capsoni F, Gerosa M, Meroni PL, Chighizola CB. Lung Disease in Antiphospholipid Syndrome. Semin Respir Crit Care Med. 2019;40(2):278-94.
Shi H, Teng JL, Sun Y, Wu XY, Hu QY, Liu HL, et al. Clinical characteristics and laboratory findings of 252 Chinese patients with anti-phospholipid syndrome: comparison with Euro-Phospholipid cohort. Clin Rheumatol. 2017;36(3):599-608.
Levine JS, Branch DW, Rauch J. The antiphospholipid syndrome. N Engl J Med. 2002;346(10):752-63.
Arvieux J, Renaudineau Y, Mane I, Perraut R, Krilis SA, Youinou P. Distinguishing features of anti-beta2 glycoprotein I antibodies between patients with leprosy and the antiphospholipid syndrome. Thromb Haemost. 2002;87(4):599-605.
Ginsburg KS, Liang MH, Newcomer L, Goldhaber SZ, Schur PH, Hennekens CH, et al. Anticardiolipin antibodies and the risk for ischemic stroke and venous thrombosis. Ann Intern Med. 1992;117(12):997-1002.
Pengo V, Biasiolo A, Pegoraro C, Cucchini U, Noventa F, Iliceto S. Antibody profiles for the diagnosis of antiphospholipid syndrome. Thromb Haemost. 2005;93(6):1147-52.
Les I, Ruiz-Irastorza G, Khamashta MA. Intensity and duration of anticoagulation therapy in antiphospholipid syndrome. Semin Thromb Hemost. 2012;38(4):339-47.
Jara LJ, Medina G, Vera-Lastra O, Barile L. The impact of gender on clinical manifestations of primary antiphospholipid syndrome. Lupus. 2005;14(8):607-12.
Pengo V, Biasiolo A, Pegoraro C, Cucchini U, Noventa F, Iliceto S. Antibody profiles for the diagnosis of antiphospholipid syndrome. Thromb Haemost. 2005;93(6):1147-52.
Pengo V, Biasiolo A, Pegoraro C, Cucchini U, Noventa F, Iliceto S. Antibody profiles for the diagnosis of antiphospholipid syndrome. Thromb Haemost. 2005;93(6):1147-52.
Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost. 2006;4(2):295-306.
Corey R. Hemoptysis. Clinical Methods: the History, Physical, and Laboratory Examinations. In: Walker HK, Hall JW, eds. Boston: Butterworth-Heinemann; 1978.
Botnga AS. Broncho-bronchial anastomosis A selective angiographic study. Ann Radiol. 1970;13:1-16.
Lordan JL, Gascoigne A, Corris PA. The pulmonary physician in critical care Illustrative case 7: Assessment and management of massive haemoptysis. Thorax. 2003;58(9):814-9.
Moen CA, Burrell A, Dunning J. Does tranexamic acid stop haemoptysis? Interact Cardiovasc Thorac Surg. 2013;17(6):991-4.
Kearon C, Akl EA, Ornelas J, Blaivas A, Jimenez D, Bounameaux H, et al. Antithrombotic Therapy for VTE Disease: CHEST Guideline and Expert Panel Report. Chest. 2016;149(2):315-52.